Artificial and Bioengineered Therapeutic Options for Corneal Endothelial Disease
Bioengineering · 30.09.2025 · 12 (10) · 1064
DOI: 10.3390/bioengineering12101064 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Bioengineering, online erschienen am 30.09.2025. Verfasst von Lanxing Fu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, East Kent Hospitals University NHS Foundation Trust, Canterbury CT1 3NG, UK. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Corneal endothelial dysfunction continues to be a primary indication for corneal transplantation globally. Due to ongoing constraints in donor tissue availability and graft durability, artificial graft technologies are increasingly recognized as viable alternatives, particularly for eyes unsuitable for conventional allogeneic transplantation.
Aim
This article examines the contemporary state of artificial corneal endothelial grafts, emphasizing technological advancements, incorporation into surgical procedures, and their developing function in meeting the unfulfilled requirements of endothelial keratoplasty.
Methods
A comprehensive synthesis of recent preclinical and clinical literature was performed, concentrating on scaffold-based constructs, cell-seeded and acellular methodologies, biomaterial characteristics, and innovative surgical delivery techniques. The review highlights translational pathways and contrasts the initial outcomes of artificial and donor-derived endothelial grafts.
Results
Advancements in regenerative biomaterials and cell culture systems have resulted in the development of functional endothelial substitutes. Engineered grafts, comprising decellularized stromal carriers, synthetic polymer matrices, and human cell-laden constructs, have demonstrated promising biocompatibility and functional results in preliminary trials. The integration of these constructs into methods akin to Descemet membrane endothelial keratoplasty (DMEK) has improved clinical viability, diminished immunologic risk, and shown potential for visual recovery.
Conclusions
Artificial endothelial grafts signify a revolutionary advancement in corneal surgery, addressing donor shortages and expanding the applications of endothelial keratoplasty. Although additional clinical validation and regulatory processes are required, existing evidence indicates that these technologies may soon transform treatment protocols for corneal endothelial disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, East Kent Hospitals University NHS Foundation Trust, Canterbury CT1 3NG, UK.
- Cornea and External Disease Department, Moorfields Eye Hospital NHS Foundation Trust, London EC1V 2PD, UK.
- Department of Ophthalmology, Maidstone and Tunbridge Wells NHS Foundation Trust, Maidstone ME16 9QQ, UK.
- Division of Rheumatology, A.O.U. "Policlinico-San Marco", 95123 Catania, Italy.
- Department of Medicine and Surgery, University of Enna "Kore", 94100 Enna, Italy.
- Imperial College Ophthalmic Research Group (ICORG) Unit, Imperial College, London NW1 5QH, UK.
ORCID-Profile: Lanxing Fu, Roberta Foti, Fabiana D'Esposito, Mutali Musa, Caterina Gagliano, Marco Zeppieri
Zitieren
APA
Fu, L., Perez, A. V., Maqsood, S., Kopsachilis, N., Foti, R., D'Esposito, F., Musa, M., Tognetto, D., Gagliano, C., & Zeppieri, M. (2025). Artificial and Bioengineered Therapeutic Options for Corneal Endothelial Disease. Bioengineering, 12(10), 1064. https://doi.org/10.3390/bioengineering12101064
Vancouver
Fu L, Perez AV, Maqsood S, Kopsachilis N, Foti R, D'Esposito F, et al. Artificial and Bioengineered Therapeutic Options for Corneal Endothelial Disease. Bioengineering. 2025;12(10):1064. doi:10.3390/bioengineering12101064
BibTeX
@article{Fu2025,
author = {Fu, Lanxing and Perez, Alfonso Vasquez and Maqsood, Sundas and Kopsachilis, Nick and Foti, Roberta and D'Esposito, Fabiana and Musa, Mutali and Tognetto, Daniele and Gagliano, Caterina and Zeppieri, Marco},
title = {Artificial and Bioengineered Therapeutic Options for Corneal Endothelial Disease},
journal = {Bioengineering},
year = {2025},
volume = {12},
number = {10},
pages = {1064},
doi = {10.3390/bioengineering12101064}
}
EUVIMED